FDA Inspection 792357 — Hospira, Inc.

Hospira, Inc. — FEI 1048698

The FDA completed an inspection of Hospira, Inc. on July 26, 2012 in Clayton, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 26, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clayton, NC (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
136121 CFR 211.100(a)Absence of Written Procedures
192021 CFR 211.166(a)(3)Valid stability test methods
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360321 CFR 211.160(b)Scientifically sound laboratory controls
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications